In this Issue:
Familial hypercholesterolaemia and type 2 diabetes prevalence
Completion of cardiac rehabilitation reduces death in diabetes
Canagliflozin improves glycaemia and bodyweight over 104 weeks
Empagliflozin reduces BP in type 2 diabetes plus hypertension
DPP-4 inhibitors do not increase CAP risk
Primary care visits and hospitalisations in indigenous patients with diabetes
SMBG reduction in type 2 diabetes
Insulin pump set use duration and fasting blood glucose in type 1 diabetes
Long-term effects of population diabetes screening
4-year evolution of insulin regimens in type 2 diabetes
Please login below to download this issue (PDF)